findmyKOL

Giuseppe Cullaro, MD

Enriched profile

Assistant Professor of Medicine; Gastroenterologist and Transplant Hepatologist · Columbia University Irving Medical Center

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 New York, NY · Northeast · United StatesSpecialtyTransplant HepatologyFocusLiver Disease and Transplantation+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2022–2025NIH funding2024–2026

Giuseppe Cullaro is Assistant Professor of Medicine; Gastroenterologist and Transplant Hepatologist at Columbia University Irving Medical Center. OpenAlex indexes 95 publications with 1,388 citations (h-index 19); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.

Data verified 11 Oct 2026

Overview

Updated 12 Oct 2026

Giuseppe Cullaro, MD, is Assistant Professor of Medicine at Columbia University Irving Medical Center. The public record shows 95 publications with 1,388 citations (h-index 19), centered on Liver Disease and Transplantation, Organ Transplantation Techniques and Outcomes, Acute Kidney Injury Research. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 5 companies, 1 NIH-funded awards (2024–2026).

  • Most recent indexed publication: 2026 · The American journal of gastroenterology
  • Top research focus: Liver Disease and Transplantation
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 5 companies

Generated from the cited public record · current as of 12 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Hypertension2 trialsHypertension, Portal2 trialsAcute Kidney Injury2 trialsAscites1 trialRenal Insufficiency1 trialNecrosis1 trialHepatorenal Syndrome1 trialChronic Kidney Disease

Research focus

OpenAlex concept fingerprint
Liver Disease and TransplantationOrgan Transplantation Techniques and OutcomesAcute Kidney Injury ResearchChronic Kidney Disease and DiabetesRenal Transplantation Outcomes and Treatments

Drugs & molecules

across trials, industry payments and publications
Terlivazgeneric · TerlipressinClinical trials—Industry payments4Publications2Creongeneric · Amylase / lipase / proteaseClinical trials—Industry payments1Publications—Iqirvogeneric · ElafibranorClinical trials—Industry payments1Publications—Rezdiffrageneric · ResmetiromClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Mallinckrodt Hospital Products Inc.Clinical trials—Industry payments4University of California, San FranciscoClinical trials2Industry payments—Abbvie Inc.Clinical trials—Industry payments1Giuseppe Cullaro, MDClinical trials1Industry payments—Ipsen Biopharmaceuticals, IncClinical trials—Industry payments1Madrigal PharmaceuticalsClinical trials—Industry payments1Pfizer Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
95publications

Distinct works indexed by OpenAlex, matched via ORCID; 30 in PubMed.

1,388citations

Total citations across indexed works.

19h-index

Hirsch index (OpenAlex). i10-index 27.

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials ↓
5companies · 2022–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2024–2026

Federally funded research awards.

View funding ↓

Contact

No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →

Clinical trials

Updated 12 Oct 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 12 Oct 2026

5 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:

NIH funding

Updated 12 Oct 2026

1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:

Publications

Updated 12 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 12 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Jennifer C. Lai47Andrew S. Allegretti32Kavish Rohit Patidar30Elizabeth C. Verna26Sumeet K. Asrani12Jevon E. Robinson11Shelsea A. St. Hillien10Tianqi Ouyang10Jessica B. Rubin9Pratima Sharma9Justin M. Belcher9Lisa B. VanWagner9Mason Lai8Eric S. Orman8Juan Carlos Q. Velez8Hani M. Wadei7Sharad Indur Wadhwani7Douglas Alano Simonetto7Kevin R. Regner7Cynthia L. Fenton7Nneka N. Ufere6Javier A. Neyra6Scott W. Biggins6Raymond T. Chung6Jin Ge6Aaron Schluger5Melinda Wang5Jennifer Jo5Brian P. Lee5Randi J. Wong5John C. Magee5Yuval A. Patel5Chiung‐Yu Huang5Pranab M. Barman5Charles E. McCulloch4Michael W. Dunn4Josh Levitsky4Laila Fozouni4Jasmine Sinha4Robert M. Wilechansky4

Online presence

Updated 12 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/giuseppe-cullaro-md-mas-74814b11

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 12 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.